Keyphrases
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Predictive Marker
100%
Prognostic Marker
100%
CYFRA 21-1
100%
CYFRA
100%
Overall Survival
42%
Failure-free Survival
42%
Overall Failure
42%
Non-small Cell Lung Cancer (NSCLC)
28%
Leukemia
14%
Randomized Phase II Trial
14%
Gemcitabine
14%
Carboplatin
14%
Eicosanoids
14%
Response to Chemotherapy
14%
Celecoxib
14%
Response to Therapy
14%
Large Reduction
14%
Cancer Serum
14%
First Cycle
14%
Cytokeratin 19 (CK19)
14%
Zileuton
14%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Cytokeratin 19 Fragment
100%
Overall Survival
75%
Failure Free Survival
75%
Phase II Trials
25%
Leukemia
25%
Chemotherapy
25%
Celecoxib
25%
Zileuton
25%
Malignant Neoplasm
25%
Icosanoid
25%
Cytokeratin 19
25%
Gemcitabine
25%
Carboplatin
25%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Failure Free Survival
100%
Eicosanoid
33%
Phase II Trials
33%
Zileuton
33%
Keratin 19
33%
Gemcitabine
33%
Celecoxib
33%
Agricultural and Biological Sciences
Lung
100%
Zileuton
25%
Eicosanoid
25%
Keratin 19
25%
Celecoxib
25%